Enlightening Lab Med - the 5th IVD Youth Entrepreneur Forum (ELMY) will be held at Primus Hotel Nanchang International Expo City (Nanchang, China) on October 25 in 2022.
With the fast growth of biotechnology and the strong support of relevant policy, the in vitro diagnostic industry has been developing rapidly in recent years. A large number of young entrepreneurs take innovation as the pursuit of value, striving to be the influential people in IVD industry.
The ELMY invited authoritative experts, successful entrepreneurs and leaders of third-party service organizations to discuss business model, share innovative ideas and experiences, prospect industry changes in IVD field. It has played a positive role in promoting young entrepreneurs to better grasp the new industrial trend, practice the new concept and integrate into the new business model.
For the standardized and sustainable development of IVD industry, we kindly welcome your participation to jointly promote the development and progress of the whole industry.
TIME (UTC/GMT+08:00)
8:30-12:00 | Tuesday, October 25, 2022
LOCATION
Primus Hotel Nanchang International Expo City
No.1100 Shangrao Street
Nanchang City, China
CONCURRENT ACTIVITIES IN 2022
The 19th China Association of Clinical Laboratory Practice Expo (CACLP)
The 2nd China IVD Supply Chain Expo (CISCE)
The 7th China Experimental Medicine Conference (CEMC)
Enlightening Lab Med - the 5th IVD Youth Entrepreneur Forum (ELMY)
The 4th China IVD Distribution Enterprise Forum (CIDEF)
The 2nd China Key Raw Material & Parts Forum (CKRMPF)
ORGANIZATION STRACTURE
Honorary chairman: JI Quan,LIN Changqing
Chairman: ZOU Jihua
Executive chairman: CAO Lin
Organizers:
Please following https://www.caivd-org.cn/en/ for more details.
Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.